相关实验视频
Updated: Jun 11, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.1K
缺铁性贫血在炎症性肠病中的作用
1Department of Pediatrics, Guru Gobind Singh Medical College & Hospital, Faridkot 151203, Punjab, India. seemadoc98@yahoo.co.uk.
World journal of clinical pediatrics
|October 1, 2024
概括
炎症性肠病 (IBD) 患者经常患有缺铁性贫血,影响生活质量. 及时诊断和治疗,通常通过替代途径,对于管理这种常见并发症至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
- 内部医学 内部医学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性肠道炎症,其全球流行率越来越高.
- 缺铁性贫血 (IDA) 是IBD常见的肠外表现,与疾病活动和复发有关.
- 贫血严重损害患者的生活质量,影响身体,认知和情感健康,增加医疗保健成本.
研究的目的:
- 审查IBD患者诊断和管理贫血的挑战和策略.
- 突出IBD中缺铁的患病率和影响.
- 在炎症的背景下讨论铁的评估和治疗的复杂性.
主要方法:
- 文献综述专注于IBD中的贫血.
- 对诊断挑战的分析,包括费里丁作为炎症标记物的作用.
- 对治疗策略的评估,包括口服和替代铁施用途径.
主要成果:
- 缺铁影响了大量的IBD患者 (高达60%),诊断不足和治疗不足很常见 (仅有14%接受治疗).
- 评估IBD中的铁状况是复杂的,因为费里丁水平随着炎症而上升,需要进行额外的测试,例如转林和.
- 口服铁疗法可能不足,因为在炎症条件下肠道吸收受损.
结论:
- 贫血,特别是IDA,是IBD的关键并发症,需要谨慎监测和管理.
- 在IBD中确切诊断铁缺乏症需要仔细解释铁研究,考虑到炎症状态.
- 静脉铁疗法通常比口服铁更好,以有效地绕过肠道炎症并补充铁储量,避免输血.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
01:30Inflammatory Bowel Disease II: Crohn's Disease
194
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
194
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
148
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
148
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:17Chronic Bowel Disorders: Introduction
403
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
403
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118